Overview
Prognostic indicators for patients with Candida spp. bloodstream infections
Antifungal pharmacokinetics/pharmacodynamics
Immunogenetics among patients with candidiasis
Management of the HIV infected patient and antiretroviral pharmacotherapy
Antibacterial drug utilization, resistance, and appropriate prescribing
Antimicrobial Stewardship
Antifungal pharmacokinetics/pharmacodynamics
Immunogenetics among patients with candidiasis
Management of the HIV infected patient and antiretroviral pharmacotherapy
Antibacterial drug utilization, resistance, and appropriate prescribing
Antimicrobial Stewardship
Current Appointments & Affiliations
Professor in Medicine
·
2022 - Present
Medicine, Infectious Diseases,
Medicine
Recent Publications
Co-administration of triazoles with calcineurin or mammalian target of rapamycin inhibitors in solid organ transplant patients hospitalized with invasive aspergillosis.
Journal Article J Antimicrob Chemother · December 19, 2025 BACKGROUND: All triazoles decrease the metabolism of calcineurin inhibitors (CNIs) and mammalian target of rapamycin (mTOR) inhibitors through CYP3A4 and P-glycoprotein inhibition leading to increased exposure and the potential for serious adverse events ( ... Full text Link to item CiteHealthcare Resource Utilization, Treatment Costs, and Mortality in Patients with Malignancies or Transplantation Who Develop Invasive Aspergillosis.
Journal Article J Fungi (Basel) · September 6, 2025 Objectives: Invasive aspergillosis (IA) poses significant risks to patients with malignancies or transplantation; however, estimates of burden-of-illness in patients with IA are sparse. We sought to assess in-hospital and outpatient healthcare resource uti ... Full text Link to item CiteBuilding upon the core elements of antifungal stewardship: practical recommendations for effective antifungal stewardship in resource-limited settings.
Journal Article Expert Rev Anti Infect Ther · August 2025 INTRODUCTION: Despite the crucial importance of effective AFS in resource-limited settings, such settings remain comparatively underserved and underrepresented in terms of resource-setting-specific guidance and research. Further practical contextualization ... Full text Link to item CiteRecent Grants
Tri-Institutional Molecular Mycology and Pathogenesis Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029Systems Biology for Infectious Diseases
ResearchPrincipal Investigator · Awarded by The Lundquist Institute · 2023 - 2028Host directed medicine in invasive fungal infection - HDM-FUN
Clinical TrialCo Investigator · Awarded by European Union · 2020 - 2026View All Grants
Education, Training & Certifications
Duke University, School of Medicine ·
2007
M.H.S.
Campbell University ·
1997
Pharm.D.
Duke University, School of Medicine ·
1992
B.S.